Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AcelRx Pharmaceuticals Inc

ACRX
Current price
1.13 USD +0.028 USD (+2.52%)
Last closed 1.1 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 14 578 978 USD
Yield for 12 month +48.38 %
1Y
3Y
5Y
10Y
15Y
ACRX
21.11.2021 - 28.11.2021

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and ARX-03, which is in Phase 2 clinical trial for the treatment of procedural anxiety and acute pain. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company also develops Fedsyra, an ephedrine pre-filled syringe that contains 10 ml of a solution of 3 mg/ml ephedrine hydrochloride for injection; and phenylephrine, a phenylephrine pre-filled syringe, which contains 10 ml of a solution of 50 mcg/ml phenylephrine for injection. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Hayward, California. Address: 25821 Industrial Boulevard, Hayward, CA, United States, 94545

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.63 USD

P/E ratio

Dividend Yield

Current Year

+651 000 USD

Last Year

+1 771 000 USD

Current Quarter

+281 000 USD

Last Quarter

+117 000 USD

Current Year

+651 000 USD

Last Year

-820 000 USD

Current Quarter

Last Quarter

+117 000 USD

Key Figures ACRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 831 000 USD
Operating Margin TTM -2828.21 %
PE Ratio
Return On Assets TTM -32.22 %
PEG Ratio
Return On Equity TTM -51.12 %
Wall Street Target Price 4.63 USD
Revenue TTM 370 000 USD
Book Value 1.08 USD
Revenue Per Share TTM 0.032 USD
Dividend Share
Quarterly Revenue Growth YOY -76.9 %
Dividend Yield
Gross Profit TTM -3 341 000 USD
Earnings Share -2.75 USD
Diluted Eps TTM -2.75 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ACRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 26.10.2022
Dividend Date

Stock Valuation ACRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 1.0597
Enterprise Value Revenue 1.0618
Price Sales TTM 39.4026
Enterprise Value EBITDA -0.103
Price Book MRQ 0.6872

Financials ACRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ACRX

For 52 weeks

0.43 USD 1.61 USD
50 Day MA 0.76 USD
Shares Short Prior Month 520 611
200 Day MA 0.84 USD
Short Ratio 4.56
Shares Short 508 110
Short Percent 3.75 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

414.58 USD Microsoft Corporation +0.12 (+0.03%)
Detailed analytics

ETF funds


M

MDAXEX

208.70 CHF iShares MDAX UCITS ETF (DE) -11.84 (-4.92%)
Detailed analytics

Metals


Gold

2169.94 USD Gold -5.94 (-0.27%)
Detailed analytics